Amkay Products Limited (BSE SME)

Apr 30, 2024 - May 3, 2024

Price ₹52 - ₹55
Premium ₹62
Lot size 2000
Allotment May 6, 2024
Listing May 8, 2024

Category Lot(s) Qty Amount Reserved
Retail 1 2000 110000 381
HNI 2 4000 220000 163

Last updated on 03 May 2024 | 05:55:03 PM

Category Offered Applied Times
QIBs 434000 75098000 173.04
HNIs 326000 321994000 987.71
Retail 762000 741530000 973.14
Total 1522000 1138622000 748.11
Total Application : 510,613
HNI Interest Cost Per Share (7 Days)
@7%
₹72.93
@8%
₹83.35
@9%
₹93.76
@10%
₹104.18
@11%
₹114.6
@12%
₹125.02
About

Anchor List

Name of Anchor No. of Shares % Portion Amount (cr)
Visionary Value Fund  4,10,000 63.08% 2.26
Meru Investment Fund PCC-Cell 1 2,40,000 36.92% 1.32
Total 650000 100.00% 3.58

IPO Reservation

Investor Category Shares Offered No. of Shares
Retail 33.25% 762000
NII (HNI) 14.22% 326000
QIB 18.93% 434000
Anchor 28.35% 650000
Market Maker 5.24% 120000
Total  100.00% 2292000

Founded in October 2007, Amkay Products Limited has emerged as a prominent name in India's healthcare industry, specializing in the production and distribution of an extensive range of medical supplies. Their offerings encompass a diverse portfolio, including medical devices like nebulizers and pulse oximeters, alongside essential disposables such as face masks and alcohol swabs. With a commitment to quality, Amkay's manufacturing facility, situated across two units in Thane, Maharashtra, spans an impressive 26,000 square feet. These facilities are equipped with state-of-the-art machinery, a meticulous testing laboratory, and comprehensive handling equipment, ensuring seamless production processes. Notably, the company's adherence to stringent quality management practices has earned it accreditation under the ISO 9001:2015 standard by QRO Certification LLP. Despite the challenges posed by the dynamic healthcare landscape, Amkay Products Limited remains steadfast in its mission to deliver excellence. As of December 31, 2023, the company proudly employs around 75 dedicated professionals across various organizational levels, underscoring its commitment to fostering a talented workforce. Through its unwavering dedication to innovation, quality, and customer satisfaction, Amkay continues to play a pivotal role in meeting the healthcare needs of institutions nationwide.

Amkay Products IPO Details

Issue Size 2,292,000 shares
(aggregating up to ₹12.61 Cr)
Fresh Issue 2,292,000 shares
(aggregating up to ₹12.61 Cr)
Issue Type Book Built Issue IPO
Listing At BSE SME
Share holding pre issue 6,363,640
Share holding post issue 8,655,640
Market Maker portion

120,000 shares

Hem Finlease

Key Performance Indicator

KPI Dec-23 Mar-23 Mar-22
ROE 24.49% 21.69% 26.81%
ROCE 21.54% 22.61% 22.88%
RONW 21.82% 19.57% 23.64%
D/E 0.48 0.61 0.7
EPS
(basic & Diluted)
3.38 2.37 2.31
P/BV 3.55    
P/E
Pre IPO
23.18    

Company Financials

Amkay Products Limited Financial Information (Restated)

Amkay Products Limited's revenue decreased by -23.22% and profit after tax (PAT) rose by 2.94% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Dec 2023 Mar 2023 Mar 2022 Mar 2021
Assets 1,887.52 1,563.77 1,580.64 1,393.47
Revenue 2,385.56 2,825.05 3,679.45 4,071.74
Profit 215.34 151.02 146.71 312.68
Net Worth 986.96 771.62 620.60 473.90
Reserves 350.59 743.95 592.93 446.23
Borrowing 476.22 469.98 433.59 136.54
Amount in ₹ Lakhs

Strength factors

Stringent Quality Assurance: The company's adherence to rigorous quality management practices, accredited under ISO 9001:2015, ensures standardized product quality, instilling confidence in customers and stakeholders alike.

Diversified Revenue Streams: With a presence in multiple geographies, Amkay enjoys diversified revenue streams, mitigating risks associated with market fluctuations and enhancing resilience against economic uncertainties.

Experienced Leadership: Bolstered by an experienced promoter and a seasoned senior management team with a proven track record and deep industry knowledge, Amkay is strategically positioned to navigate challenges and capitalize on emerging opportunities effectively.

Risk Factors

Declining Revenue Trend: Persistent decline in revenue over the past two financial years raises concerns about the company's ability to sustain profitability and maintain market competitiveness amidst evolving industry dynamics and economic challenges.

Historical Negative Cash Flows: Historical instances of negative operating, investing, and financing cash flows indicate potential liquidity constraints and financial instability, posing risks to the company's operational sustainability and capital investment capabilities.

Potential Future Operating Losses: Continued operating losses or negative cash flows in the future could significantly impair Amkay's results of operations and financial condition, hampering its ability to meet debt obligations, invest in growth initiatives, and sustain shareholder value. Such scenarios may also erode investor confidence and hinder the company's access to capital markets for necessary funding.

Registrar

Bigshare Services Pvt Ltd

Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/ipo_status.html